Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 195

1.

5.6 The Control of Hypertension In Pregnancy Study (CHIPS) randomised controlled trial.

Magee L, von Dadelszen P, Rey E, Ross S, Asztalos E, Murphy K, Menzies J, Sanchez J, Singer J, Gafni A, Gruslin A, Hutton E, Lee S, Logan A, Ganzevoort J, Welch Derriford Hosp R, Thornton J.

Arch Dis Child Fetal Neonatal Ed. 2014 Jun;99(Suppl 1):A5-A6. doi: 10.1136/archdischild-2014-306576.15.

PMID:
25021266
[PubMed - as supplied by publisher]
2.

Predicting complications in pre-eclampsia: external validation of the fullPIERS model using the PETRA trial dataset.

Akkermans J, Payne B, Dadelszen Pv, Groen H, Vries Jd, Magee LA, Mol BW, Ganzevoort W.

Eur J Obstet Gynecol Reprod Biol. 2014 Aug;179:58-62. doi: 10.1016/j.ejogrb.2014.05.021. Epub 2014 Jun 2.

PMID:
24965981
[PubMed - in process]
3.

Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary.

Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Hypertension Guideline Committee, Magee LA, Audibert F, Bujold E, Côté AM, Douglas MJ, Eastabrook G, Firoz T, Gibson P, Gruslin A, Hutcheon J, Koren G, Lange I, Leduc L, Logan AG, MacDonell KL, Moutquin JM, Sebbag I.

J Obstet Gynaecol Can. 2014 May;36(5):416-38.

PMID:
24927294
[PubMed - in process]
4.

Venous thromboembolism and antithrombotic therapy in pregnancy.

Chan WS, Rey E, Kent NE; VTE in Pregnancy Guideline Working Group, Chan WS, Kent NE, Rey E, Corbett T, David M, Douglas MJ, Gibson PS, Magee L, Rodger M, Smith RE.

J Obstet Gynaecol Can. 2014 Jun;36(6):527-53.

PMID:
24927193
[PubMed - in process]
5.

Letter to the editor: "34 weeks" of gestation-lost in translation.

Magee LA, von Dadelszen P, Asztalos E, Ross S, Rey E.

J Obstet Gynaecol Can. 2014 Jun;36(6):480-1. No abstract available.

PMID:
24927184
[PubMed - in process]
6.

Pre-eclampsia: an update.

von Dadelszen P, Magee LA.

Curr Hypertens Rep. 2014 Aug;16(8):454. doi: 10.1007/s11906-014-0454-8.

PMID:
24915961
[PubMed - in process]
7.

Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.

Firoz T, Magee L, MacDonell K, Payne B, Gordon R, Vidler M, von Dadelszen P; the Community Level Interventions for Pre-eclampsia (CLIP) Working Group.

BJOG. 2014 May 16. doi: 10.1111/1471-0528.12737. [Epub ahead of print]

PMID:
24832366
[PubMed - as supplied by publisher]
8.

Magnesium sulphate for the management of preeclampsia and eclampsia in low and middle income countries: a systematic review of tested dosing regimens.

Gordon R, Magee LA, Payne B, Firoz T, Sawchuck D, Tu D, Vidler M, de Silva D, von Dadelszen P.

J Obstet Gynaecol Can. 2014 Feb;36(2):154-63. Review.

PMID:
24518915
[PubMed - indexed for MEDLINE]
9.

A risk prediction model for the assessment and triage of women with hypertensive disorders of pregnancy in low-resourced settings: the miniPIERS (Pre-eclampsia Integrated Estimate of RiSk) multi-country prospective cohort study.

Payne BA, Hutcheon JA, Ansermino JM, Hall DR, Bhutta ZA, Bhutta SZ, Biryabarema C, Grobman WA, Groen H, Haniff F, Li J, Magee LA, Merialdi M, Nakimuli A, Qu Z, Sikandar R, Sass N, Sawchuck D, Steyn DW, Widmer M, Zhou J, von Dadelszen P; miniPIERS Study Working Group.

PLoS Med. 2014 Jan;11(1):e1001589. doi: 10.1371/journal.pmed.1001589. Epub 2014 Jan 21.

PMID:
24465185
[PubMed - in process]
Free PMC Article
10.

ACP Journal Club. Fluconazole use during the first trimester of pregnancy was not associated with most major birth defects.

Magee LA.

Ann Intern Med. 2014 Jan 21;160(2):JC12. doi: 10.7326/0003-4819-160-2-201401210-02012. No abstract available.

PMID:
24445710
[PubMed - indexed for MEDLINE]
11.

Magnesium sulphate for fetal neuroprotection: a cost-effectiveness analysis.

Bickford CD, Magee LA, Mitton C, Kruse M, Synnes AR, Sawchuck D, Basso M, Senikas VM, von Dadelszen P; MAG-CP Working Group.

BMC Health Serv Res. 2013 Dec 19;13:527. doi: 10.1186/1472-6963-13-527.

PMID:
24350635
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Measuring maternal health: focus on maternal morbidity.

Firoz T, Chou D, von Dadelszen P, Agrawal P, Vanderkruik R, Tunçalp O, Magee LA, van Den Broek N, Say L; Maternal Morbidity Working Group.

Bull World Health Organ. 2013 Oct 1;91(10):794-6. doi: 10.2471/BLT.13.117564. Epub 2013 Aug 6. No abstract available.

PMID:
24115804
[PubMed - in process]
Free PMC Article
13.

Accelerated hypo-fractionated radiotherapy for non small cell lung cancer: results from 4 UK centres.

Din OS, Harden SV, Hudson E, Mohammed N, Pemberton LS, Lester JF, Biswas D, Magee L, Tufail A, Carruthers R, Sheikh G, Gilligan D, Hatton MQ.

Radiother Oncol. 2013 Oct;109(1):8-12. doi: 10.1016/j.radonc.2013.07.014. Epub 2013 Oct 3.

PMID:
24094626
[PubMed - in process]
14.

Unexpected random urinary protein:creatinine ratio results-limitations of the pyrocatechol violet-dye method.

De Silva DA, Halstead AC, Côté AM, Sabr Y, von Dadelszen P, Magee LA.

BMC Pregnancy Childbirth. 2013 Jul 17;13:152. doi: 10.1186/1471-2393-13-152.

PMID:
23865673
[PubMed - in process]
Free PMC Article
15.

Prevention and treatment of postpartum hypertension.

Magee L, von Dadelszen P.

Cochrane Database Syst Rev. 2013 Apr 30;4:CD004351. doi: 10.1002/14651858.CD004351.pub3. Review.

PMID:
23633317
[PubMed - indexed for MEDLINE]
16.

Pharmacotherapy for preeclampsia in low and middle income countries: an analysis of essential medicines lists.

Lalani S, Firoz T, Magee LA, Sawchuck D, Payne B, Gordon R, Vidler M, von Dadelszen P.

J Obstet Gynaecol Can. 2013 Mar;35(3):215-23.

PMID:
23470109
[PubMed - indexed for MEDLINE]
17.

Cosmetic and reconstructive breast surgery in adolescents: psychological, ethical, and legal considerations.

Crerand CE, Magee L.

Semin Plast Surg. 2013 Feb;27(1):72-8. doi: 10.1055/s-0033-1343999.

PMID:
24872744
[PubMed]
Free PMC Article
18.

Protecting intellectual property associated with Canadian academic clinical trials--approaches and impact.

Ross S, Magee L, Walker M, Wood S.

Trials. 2012 Dec 27;13:243. doi: 10.1186/1745-6215-13-243.

PMID:
23270486
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Indications for, timing of, and modes of delivery in a national cohort of women admitted with antepartum hemorrhage at 22+0 to 28+6 weeks' gestation.

Sabourin JN, Lee T, Magee LA, von Dadelszen P, Demianczuk N.

J Obstet Gynaecol Can. 2012 Nov;34(11):1043-52.

PMID:
23231842
[PubMed - in process]
20.

Performance of the fullPIERS model in predicting adverse maternal outcomes in pre-eclampsia using patient data from the PIERS (Pre-eclampsia Integrated Estimate of RiSk) cohort, collected on admission.

Payne B, Hodgson S, Hutcheon JA, Joseph KS, Li J, Lee T, Magee LA, Qu Z, von Dadelszen P; PIERS Study Group.

BJOG. 2013 Jan;120(1):113-8. doi: 10.1111/j.1471-0528.2012.03496.x. Epub 2012 Oct 19.

PMID:
23078362
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk